This invention provides a method for treating an eye disease in a patient comprising: providing a photosensitive prodrug that releases upon exposure to light an active ingredient to treat the eye disease; administering the prodrug in a pharmaceutically accepted vehicle to the subject, and exposing t.....
[Detail]
Disclosed Herein Are Novel Light-Emitting Materials Of Formula I And Ii Below. These New Complexes Are Synthesized And Found To Be Sufficiently Stable To Allow Sublimation And Vacuum Deposition. These New Emitters Are Electrophosphorescent And Can Be Used In Organic Light-Emitting Devices (Oleds) Fo.....
[Detail]
The subject invention provides a method for optimal isolation of cimiracemate A for subsequent use as a therapeutic agent or dietary supplement in single entry or in combination with other treatment modalities. In addition, the subject invention discloses cimiracemate A as a bioactive marker that ca.....
[Detail]
The Present Invention Provides An Oral Formulation Of Arsenic Trioxide (As2o3) For The Treatment Of A Variety Of Hematological Malignancies, Including Acute Myeloid Leukemia (Aml) And Acute Promyelocytic Leukemia (Apl). The Present Invention Also Provides Methods For Making The Oral Arsenic Trioxide.....
[Detail]
The invention provides a method of treating liver cancer comprising administering anti-DKK1 monoclonal antibody to a subject in need thereof. Anti-DKK1 monoclonal antibody can also be administered for preventing or ameliorating cancer metastasis and for neutralizing serum and tissue DKK1 in liver ca.....
[Detail]
| |< <- | [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] | -> >| |
